Provided by Tiger Trade Technology Pte. Ltd.

Zura Bio

6.45
+0.15002.38%
Volume:1.96M
Turnover:12.50M
Market Cap:618.10M
PE:-5.93
High:6.49
Open:6.32
Low:6.18
Close:6.30
52wk High:7.44
52wk Low:1.88
Shares:95.83M
Float Shares:51.20M
Volume Ratio:1.40
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0870
EPS(LYR):-1.0600
ROE:-51.01%
ROA:-31.23%
PB:3.14
PE(LYR):-6.08

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zura Bio (ZURA)

TIPRANKS
·
Jul 08

Zura Bio Releases Investor Presentation on Tibulizumab Dual IL-17 and BAFF Blockade in Immune Disorders

Reuters
·
Jul 02

Zura Bio Price Target Maintained with a $15.00/share by Wedbush

Dow Jones
·
Jul 01

We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely

Simply Wall St.
·
Jun 30

Guggenheim Sticks to Its Buy Rating for Zura Bio (ZURA)

TIPRANKS
·
Jun 30

Tenaya Therapeutics Names Eric Hyllengren CFO

MT Newswires Live
·
Jun 29

Zura Bio Completes Phase 2 HS Trial Enrollment for Tibulizumab, Exceeding Target at 247 Participants

Reuters
·
Jun 29

Zura Bio VP, Principal Accounting Officer Mathew Marlyn Teresa files initial beneficial ownership statement

Reuters
·
Jun 23

Zura Bio Shareholders Back Board, Auditor and Equity Plan

TIPRANKS
·
Jun 19

Zura Bio shareholders approve amended 2023 equity incentive plan at annual meeting

Reuters
·
Jun 19

Zura Bio (ZURA) Gets a Buy from Oppenheimer

TIPRANKS
·
Jun 12

Zura Bio posts investor deck spotlighting tibulizumab dual IL-17 and BAFF approach for immune disorders

Reuters
·
Jun 03

Zura Bio Announces Board Resignation, Governance Stability Affirmed

TIPRANKS
·
May 23

Zura Bio director Someit Sidhu resigns from board effective May 21

Reuters
·
May 23

Zura Bio grants Chief Business Officer option for 600,000 shares at $4.8###

Reuters
·
May 14

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 14

Zura Bio appoints Muzammil Mustufa chief business officer

Reuters
·
May 13

Zura Bio Expands Leadership Team With Appointment of Muzammil Mustufa as Chief Business Officer

THOMSON REUTERS
·
May 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 09

Guggenheim Sticks to Its Buy Rating for Zura Bio (ZURA)

TIPRANKS
·
May 08